** Shares of medical products maker Baxter International BAX.N fall 11.2% to $19.91 premarket

** Co now expects annual adjusted profit in the range of $2.35 and $2.40 per share, down from its previous projection of $2.42 and $2.52 per share; analysts expect a profit of $2.44 per share, as per LSEG-compiled data

** Co reports Q3 revenue of $2.84 billion, vs est of $2.88 billion

** Co posts adjusted quarterly profit of 69 cents per share, surpassing estimates of 60 cents

** As of last close, BAX stock was down 23.1% YTD

(Reporting by Padmanabhan Ananthan and Sahil Pandey)

((Sahil.Pandey@thomsonreuters.com))